Trials / Completed
CompletedNCT00144664
Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)
An Open-Label, Phase III Study to Evaluate the Efficacy, Safety and PK of MRA in Patients With pJIA
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 19 (actual)
- Sponsor
- Chugai Pharmaceutical · Industry
- Sex
- All
- Age
- 2 Years – 19 Years
- Healthy volunteers
- Not accepted
Summary
This is an open-label, Phase III study to evaluate the efficacy, safety and PK of MRA in patients with pJIA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MRA(Tocilizumab) |
Timeline
- Start date
- 2004-11-01
- Primary completion
- 2005-04-01
- Completion
- 2005-10-01
- First posted
- 2005-09-05
- Last updated
- 2008-07-30
Source: ClinicalTrials.gov record NCT00144664. Inclusion in this directory is not an endorsement.